Company Name:NovoCure Limited
CEO: Asaf Danziger

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors.


Key numbers

Market Capitalization:8311416620
Shares Outstanding: 98969000
Float: 79213797.91
Next Earning Date:2020-02-20
TTm EPS: -0.2896
TTm Dividend Rate:
200 days moving average:64.32
50 days moving average: 76.52
One day percent Change: 22.96



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,